INFINITE EPIGENETICS

Serial Number 99015950
656

Registration Progress

Application Filed
Jan 23, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
99015950
Deadline
October 3, 2025
Description
Respond to Examiner's Amendment or Priority Action
Filing Date
January 23, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
656
Status Date
Jul 3, 2025
Application
Pending
Classes
001 005 009 044

Rights Holder

Infinite Epigenetics, Inc.

03
Address
881 Corporate Drive
Lexington, KY 40503

Ownership History

Infinite Epigenetics, Inc.

Original Applicant
03
Lexington, KY

Legal Representation

Attorney
Patrick Michael Torre

Application History

9 events
Date Code Type Description
Jul 3, 2025 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jul 3, 2025 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 3, 2025 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jul 3, 2025 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 3, 2025 DOCK D ASSIGNED TO EXAMINER
Jun 27, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 27, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Jan 23, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Diagnostic preparations for scientific or research use
Class 005
Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes
Class 009
Downloadable computer software for assessing biological age and diagnostic predictors of disease
Class 044
Remote monitoring of medical data for medical diagnosis and treatment

Additional Information

Design Mark
The mark consists of a stylized infinity symbol positioned to the left of the wording "infinite epigenetics".

Classification

International Classes
001 005 009 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EPIGENETICS"